Gary M. Reisfield, MD
The FDA's decision not to approve generic versions of original-formula OxyContin may keep drug costs high for patients with pain, but the benefits of the newer, abuse-resistant formulation outweigh this harm.
Virtual Mentor. 2014; 16(4):279-283. doi:
10.1001/virtualmentor.2014.16.4.pfor1-1404.